3Wagstaff A, Frampton J, Croom K. Tegaserod:a review of its use in the management of irritable bowel syndrome with constipation in women[J], Drugs. 2003, 63:1101-1120.
5Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable syndrome and control subjects with painful and nonpainful rectal distention [ J ]. Gastroenterology, 2000, 118 : 842 -848.
8Spiller RC, Jenkin D, Thomley JP, et al. Increased rectal mucosal entereendocrine cells, T lymphocytes, and increased gut permeability following acute campylobacter enteritis and in post-dysenteric irritable syndrome[ J ]. Gut, 2000, 47:804-811.
9Gwee KA, Leong YL, Graham C, el al. The role of psychological and biological factors in postinfeetive gut dysfunction [J]. Gut,1999, 44:306-307.
10Farthing MJG. New drugs in the management of the irritable bowel syndrome[ J ]. Drug, 1999, 56 : 11-21,
10Vallance BA, Blennethassett PA and Collins SM. Murine Trichinosis: A model of post-infective smooth muscle dysfunction. Gastroenterol, 1994, 106:A582
